Malignant tumour of oesophagus

SCOPE1

Year Started: 2008

Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial.



Access:
Open only through collaboration
Type:
Clinical Trial
Status:
Completed
Consent restrictions:
No restrictions


Associated Data Type Procurement Timeframe
Biomarker datasets 3 - 6 months
Clinical records 3 - 6 months
Followup records 3 - 6 months
Freezer temperature logs 0 - 3 months
Genomic datasets 3 - 6 months
Imaging data > 6 months
Pathology records 3 - 6 months
Physiological/biochemical measurements 3 - 6 months
Quality indicators 0 - 3 months
Treatment records 3 - 6 months


Female

Adult (> 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Tissue specimen Surgical procedure (procedure) RT N/A Not applicable 100%


Male

Adult (> 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Tissue specimen Surgical procedure (procedure) RT N/A Not applicable 100%

Malignant tumor of lung (disorder)

FRAGMATIC

Year Started: 2007

Randomized Phase III Trial of Standard Therapy Plus Low Molecular Weight Heparin in Patients With Lung Cancer: FRAGMATIC Trial.



Access:
Open only through collaboration
Type:
Clinical Trial
Status:
Completed
Consent restrictions:
No restrictions


Associated Data Type Procurement Timeframe
Biomarker datasets 3 - 6 months
Clinical records 3 - 6 months
Followup records 3 - 6 months
Genomic datasets 3 - 6 months
Pathology records 3 - 6 months
Physiological/biochemical measurements 3 - 6 months
Quality indicators 3 - 6 months
Treatment records 3 - 6 months


Male

Adult (> 40 years)

101 - 500 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Serum -60°C to -85°C N/A Not applicable 100%


Female

Adult (> 40 years)

101 - 500 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Serum -60°C to -85°C N/A Not applicable 100%

Malignant tumor of pancreas (disorder)

SCALOP

Year Started: 2009

Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial.



Access:
Open only through collaboration
Type:
Clinical Trial
Status:
Completed
Consent restrictions:
No restrictions


Associated Data Type Procurement Timeframe
Biomarker datasets 3 - 6 months
Clinical records 3 - 6 months
Followup records 3 - 6 months
Freezer temperature logs 3 - 6 months
Imaging data 3 - 6 months
Physiological/biochemical measurements 3 - 6 months
Quality indicators 3 - 6 months


Male

Adult (> 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Serum -60°C to -85°C N/A Not applicable 100%


Female

Adult (> 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Serum -60°C to -85°C N/A Not applicable 100%

Malignant tumour of oesophagus

NEOSCOPE

Year Started: 2013

A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma



Access:
Open only through collaboration
Type:
Clinical Trial
Status:
Completed
Consent restrictions:
No restrictions


Associated Data Type Procurement Timeframe
Biomarker datasets 3 - 6 months
Clinical records 3 - 6 months
Followup records 3 - 6 months
Freezer temperature logs 3 - 6 months
Pathology records 3 - 6 months
Quality indicators 3 - 6 months


Male

Adult (> 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Tissue specimen Surgical procedure (procedure) RT N/A Affected 100%


Female

Adult (> 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Tissue specimen Surgical procedure (procedure) RT N/A Affected 100%


Male

Adult (> 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Serum -60°C to -85°C N/A Not applicable 100%


Female

Adult (> 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Serum -60°C to -85°C N/A Not applicable 100%

Malignant tumor of colon (disorder)

COPERNICUS

Year Started: 2012

A phase II single arm feasibility trial of neoadjuvant chemotherapy (NAC) with oxaliplatin/fluorouracil (OxMdG) then short-course preoperative radiotherapy (SCPRT) then immediate surgery in operable rectal cancer (ORC): COPERNICUS (NCT01263171).



Access:
Open only through collaboration
Type:
Clinical Trial
Status:
Completed
Consent restrictions:
No restrictions


Associated Data Type Procurement Timeframe
Biomarker datasets 3 - 6 months
Clinical records 3 - 6 months
Followup records 3 - 6 months
Freezer temperature logs 3 - 6 months
Pathology records 3 - 6 months
Physiological/biochemical measurements 3 - 6 months
Quality indicators 3 - 6 months


Male

Adult (> 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Tissue specimen Surgical procedure (procedure) RT N/A Affected 100%


Female

Adult (> 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Tissue specimen Surgical procedure (procedure) RT N/A Affected 100%


Male

Adult (> 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Plasma -60°C to -85°C N/A Not applicable 100%


Female

Adult (> 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Plasma -60°C to -85°C N/A Not applicable 100%

Malignant tumor of breast (disorder)

FAKTION

Year Started: 2015

A phase 1b/2 randomised placebo controlled trial of fulvestrant +/- AZD5363 in postmenopausal women with advanced breast cancer previously treated with a third generation aromatase inhibitor



Access:
Access restricted at present
Type:
Disease specific
Status:
In progress
Consent restrictions:
No restrictions


Associated Data Type Procurement Timeframe
Biomarker datasets > 6 months
Clinical records > 6 months
Followup records > 6 months
Freezer temperature logs > 6 months
Pathology records > 6 months
Physiological/biochemical measurements > 6 months
Quality indicators > 6 months
Treatment records > 6 months
Psychological data > 6 months


Male

Adult (> 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Tissue specimen Surgical procedure (procedure) RT Paraffin Affected 100%


Female

Adult (> 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Tissue specimen Surgical procedure (procedure) RT Paraffin Affected 100%